Firebrick Pharma Limited (ASX: FRE)
Australia
· Delayed Price · Currency is AUD
0.0560
+0.0020 (3.70%)
Dec 20, 2024, 3:45 PM AEST
Firebrick Pharma Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Cash & Equivalents | 0.82 | 0.82 | 2.35 | 7.14 | 1.15 | 0.09 |
Short-Term Investments | - | - | - | - | 0.01 | - |
Cash & Short-Term Investments | 0.82 | 0.82 | 2.35 | 7.14 | 1.16 | 0.09 |
Cash Growth | -64.97% | -64.97% | -67.04% | 514.47% | 1153.94% | - |
Accounts Receivable | 0 | 0 | - | - | - | - |
Other Receivables | 0.95 | 0.95 | 0.14 | 1.08 | 0.5 | 0.56 |
Receivables | 0.95 | 0.95 | 0.14 | 1.08 | 0.5 | 0.56 |
Inventory | 0.24 | 0.24 | - | - | - | - |
Prepaid Expenses | - | - | - | - | 0 | 0 |
Other Current Assets | 0.08 | 0.08 | 0.1 | 0.1 | - | - |
Total Current Assets | 2.09 | 2.09 | 2.59 | 8.33 | 1.67 | 0.65 |
Property, Plant & Equipment | 0.03 | 0.03 | 0.03 | 0.04 | 0.02 | 0 |
Other Long-Term Assets | 0.29 | 0.29 | 0.36 | 0.36 | 0.08 | - |
Total Assets | 2.41 | 2.41 | 2.98 | 8.73 | 1.76 | 0.65 |
Accounts Payable | 0.07 | 0.07 | 0.2 | 0.04 | 0.03 | 0.2 |
Accrued Expenses | 0.1 | 0.1 | 0.14 | 0.34 | 0.1 | 0.01 |
Other Current Liabilities | 0.12 | 0.12 | 0.17 | 0.08 | 0.08 | - |
Total Current Liabilities | 0.29 | 0.29 | 0.51 | 0.45 | 0.21 | 0.21 |
Long-Term Debt | - | - | - | - | - | 0.05 |
Total Liabilities | 0.29 | 0.29 | 0.51 | 0.45 | 0.21 | 0.26 |
Common Stock | 17.88 | 17.88 | 17.07 | 16 | 5.77 | 2.66 |
Retained Earnings | -16.51 | -16.51 | -15.58 | -8.81 | -5.03 | -2.59 |
Comprehensive Income & Other | 0.74 | 0.74 | 0.99 | 1.08 | 0.81 | 0.33 |
Shareholders' Equity | 2.12 | 2.12 | 2.48 | 8.28 | 1.55 | 0.39 |
Total Liabilities & Equity | 2.41 | 2.41 | 2.98 | 8.73 | 1.76 | 0.65 |
Total Debt | - | - | - | - | - | 0.05 |
Net Cash (Debt) | 0.82 | 0.82 | 2.35 | 7.14 | 1.16 | 0.04 |
Net Cash Growth | -64.97% | -64.97% | -67.04% | 514.47% | 2935.77% | - |
Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.06 | 0.01 | 0.00 |
Filing Date Shares Outstanding | 195.31 | 195.31 | 176.25 | 169.2 | 37.21 | 30.26 |
Total Common Shares Outstanding | 195.31 | 195.31 | 176.25 | 168.84 | 37.21 | 30.26 |
Working Capital | 1.8 | 1.8 | 2.08 | 7.88 | 1.45 | 0.44 |
Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.05 | 0.04 | 0.01 |
Tangible Book Value | 2.12 | 2.12 | 2.48 | 8.28 | 1.55 | 0.39 |
Tangible Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.05 | 0.04 | 0.01 |
Machinery | - | - | - | - | 0.02 | 0 |
Source: S&P Capital IQ. Standard template. Financial Sources.